Document and Entity Information [Abstract] Document and Entity Information Statement [Table] Statement [Line Items] Document Type Document Quarterly Report Document Period End Date Document Transition Report Entity File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Shell Company Entity Common Stock, Shares Outstanding Entity Central Index Key Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag Condensed Consolidated Balance Sheets Assets [Abstract] Assets Assets, Current [Abstract] Current assets: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash and cash equivalents at end of period Cash and cash equivalents at beginning of period Cash and cash equivalents Receivables, Net, Current Tax incentive and other receivables Prepaid Expense and Other Assets, Current Prepaid expenses and other assets Prepaid expenses and other current assets Assets, Current Total current assets Property, Plant and Equipment, Net Property and equipment, net Finite-Lived Intangible Assets, Net Intangible assets, net Patent, Net Other Assets, Noncurrent Other assets Assets Total assets Liabilities and Equity [Abstract] Liabilities and stockholders' equity (deficit) Liabilities, Current [Abstract] Current liabilities: Accounts Payable, Current Accounts payable Accrued Expenses and Other Current Liabilities, Current Accrued expenses and other liabilities Accrued expenses and other current liabilities Liabilities, Current Total current liabilities Warrants and Rights Outstanding Warrant liabilities Liabilities Total liabilities Commitments and Contingencies. Commitments and contingencies (Note 5) Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Stockholders' deficit: Preferred Stock, Value, Issued Series C Preferred stock, $0.01 par value, 5,000,000 shares authorized, 7,440 shares issued and 6,737 shares outstanding at June 30, 2026 and December 31, 2025 Common Stock, Value, Issued Common stock, $0.01 par value, 250,000,000 shares authorized, 15,264,812 and 9,067,774 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively Additional Paid in Capital, Common Stock Additional paid-in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated deficit Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive (loss) income Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Balance Balance Total stockholders' equity (deficit) Liabilities and Equity Total liabilities and stockholders' equity (deficit) Preferred Stock, Par or Stated Value Per Share Preferred stock, par value (in dollars per share) Preferred Stock, Shares Authorized Preferred stock, shares authorized (in shares) Preferred Stock, Shares Issued Preferred stock, shares issued (in shares) Preferred Stock, Shares Outstanding Preferred stock, shares outstanding (in shares) Common Stock, Par or Stated Value Per Share Common stock, par value (in dollars per share) Common Stock, Shares Authorized Common stock, shares authorized (in shares) Common Stock, Shares, Issued Common stock, shares issued (in shares) Common Stock, Shares, Outstanding Common stock, shares outstanding (in shares) Condensed Consolidated Statements of Operations Revenue. Revenue Operating Expenses [Abstract] Operating expenses: Research and Development Expense Research and development Total research and development expenses General and Administrative Expense General and administrative Total general and administrative Other operating income expense Other operating income expense Other operating income Operating Expenses Total operating expenses Operating Income (Loss) Loss from operations Fair Value Adjustment of Warrants Change in fair value of warrant liability Change in fair value of warrant liability Other income, net Other loss (income), net (d) Other (loss) income, net Net (loss) income Net (loss) income Net Income (Loss) Available to Common Stockholders, Basic Net (loss) income attributable to common stockholders, basic Net (loss) income attributable to common stockholders, basic Net Income (Loss) Available to Common Stockholders, Diluted Net (loss) income attributable to common stockholders, diluted Net (loss) income attributable to common stockholders, diluted Weighted Average Number of Shares Outstanding, Basic Weighted-average shares of common stock outstanding, basic (in shares) Earnings Per Share, Basic Net (loss) income per share of common stock, basic (in dollars per share) Weighted Average Number of Shares Outstanding, Diluted Weighted-average shares of common stock outstanding, diluted (in shares) Earnings Per Share, Diluted Net (loss) income per share of common stock, diluted (in dollars per share) Undistributed Earnings (Loss) Allocated to Participating Securities, Basic Net (loss) income attributable to Series C Preferred stockholders, basic Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted Net (loss) income attributable to Series C Preferred stockholders, diluted Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that preferred shares or units have been outstanding to the total time in that period. Weighted Average Number of Preferred Stock Outstanding, Basic Weighted-average shares of Series C Preferred outstanding, basic (in shares) The average number of preferred shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Weighted Average Number of Preferred Stock Outstanding, Diluted Weighted-average shares of Series C Preferred outstanding, diluted (in shares) The amount of net income (loss) for the period per each share of preferred stock or unit outstanding during the reporting period. Earnings Per Share Of Preferred Stock, Basic Net (loss) income per share of Series C Preferred, basic (in dollars per share) The amount of diluted net income (loss) for the period available to each share of preferred stock or unit outstanding during the reporting period . Earnings Per Share Of Preferred Stock, Diluted Net (loss) income per share of Series C Preferred, diluted (in dollars per share) Condensed Consolidated Statements of Comprehensive (Loss) Income Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent [Abstract] Other comprehensive (loss) income Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Foreign currency translation adjustments Other Comprehensive Income (Loss), Net of Tax Other comprehensive (loss) income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive (loss) income Consolidated Statement of Convertible Preferred Stock and Stockholders' Deficit Equity Components [Axis] Equity Component [Domain] Preferred Stock [Member] Preferred Stock Common Stock Common Stock Additional Paid in Capital Additional Paid in Capital Accumulated deficit Accumulated deficit Accumulated other comprehensive (loss) income Accumulated other comprehensive income (loss) Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity (Deficit) Shares, Issued Balance (in shares) Balance (in shares) Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Stock-based compensation Number of shares of stock issued during the period pursuant to transaction cost of acquisitions. Stock Issued During Period, Shares, Transaction Cost of Acquisitions Transaction costs paid through the issuance of stock (in shares) Stock Issued During Period, Value, Restricted Stock Award, Gross Shares issued for vested restricted stock units Stock Issued During Period, Shares, Restricted Stock Award, Gross Shares issued for vested restricted stock units (in shares) Stock Issued During Period, Value, New Issues Issuance of common stock and warrants, net of offering costs Stock Issued During Period, Shares, New Issues Issuance of common stock and warrants, net of offering costs (in shares) Amount of increase in additional paid in capital (APIC) resulting from the reclassification of warrant liability upon exercise of prefunded warrants and amended warrant agreements. Adjustments to Additional Paid in Capital, Reclassification Of Warrant Liability Reclassification of warrant liability upon exercise of prefunded warrants and amended warrant agreements Represents the amount of common stock issued for exercise of prefunded warrants. Stock Issued During Period, Value, Exercise of Prefunded Warrants Exercise of prefunded warrants Represents the share amount of common stock issued for exercise of prefunded warrants. Stock Issued During Period, Share, Exercise of Prefunded Warrants Exercise of prefunded warrants (in shares) Stock Issued During Period, Value, Warrants Exercised Conversion of Series C Preferred shares into common stock Stock Issued During Period, Shares, Warrants Exercised Conversion of Series C Preferred shares into common stock (in shares) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Other comprehensive loss Condensed Consolidated Statements of Cash Flows Net Cash Provided by (Used in) Operating Activities [Abstract] Operating activities: Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net (loss) income Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustment to reconcile net (loss) income to net cash used in operating activities: Depreciation, Depletion and Amortization Depreciation and amortization Share-based Compensation Stock-based compensation Increase (Decrease) in Operating Capital [Abstract] Changes in assets and liabilities: Increase (Decrease) in Receivables Receivables Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Increase (Decrease) in Other Noncurrent Assets Other assets Increase (Decrease) in Accounts Payable Accounts payable Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Accrued expenses and other current liabilities Increase (Decrease) in Contract With Customer Liability Deferred revenue Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Net Cash Provided by (Used in) Financing Activities [Abstract] Financing activities: Proceeds from Issuance of Common Stock Proceeds from sale of common stock pursuant to the ATM The cash inflow from the additional capital contribution to the entity from common stock and warrants. Gross Proceeds From Issuance Of Common Stock And Warrants Proceeds from sale of common stock pursuant to the April Offering Payments of Stock Issuance Costs Payment of offering costs Payment of offering costs Proceeds from Warrant Exercises Proceeds from exercised prefunded warrants Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Effect of Exchange Rate on Cash and Cash Equivalents Effect of foreign currency translation on cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Net increase (decrease) in cash and cash equivalents Supplemental Cash Flow Information [Abstract] Supplemental disclosure of cash flow information: Amount of offering costs included in accounts payable. Offering Costs Included In Accounts Payable Deferred offering costs in accounts payable Amount of reclassification of warrant liability in to permanent equity. Reclassification Of Warrant Liability Into Permanent Equity Reclassification of warrant liability upon exercise of prefunded warrants and amended warrant agreements Summary of Significant Accounting Policies Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Balance Sheet Detail Supplemental Balance Sheet Disclosures [Text Block] Balance Sheet Detail Intangible Assets Intangible Assets Disclosure [Text Block] Intangible Assets Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Convertible Preferred Stock and Stockholders' Equity (Deficit) The entire disclosure for temporary equity. Temporary Equity [Text Block] Convertible Preferred Stock and Stockholders' Equity (Deficit) Warrants The entire disclosure for warrants. Warrants [Text Block] Warrants Stock-Based Compensation Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Stock-Based Compensation Segment Information Segment Reporting Disclosure [Text Block] Segment Information Research and Development Arrangements and Related Party Transactions The entire disclosure for research agreements. Research Agreements Disclosure [Text Block] Research and Development Arrangements and Related Party Transactions Basis of Accounting, Policy [Policy Text Block] Basis of Presentation Use of Estimates, Policy [Policy Text Block] Use of Estimates Disclosure of accounting policy for unaudited interim financial information. Unaudited Interim Financial Information Policy Text Block Unaudited Interim Financial Information Segment Reporting, Policy [Policy Text Block] Segment Information Disclosure of accounting policy of concentration of credit risk and off balance sheet risks. Concentration Of Credit Risk And Off Balance Sheet Risk Policy Text Block Concentrations of Credit Risk and Off-Balance Sheet Risk Disclosure of accounting policy for significant accounting policies. Significant Accounting Policies Policy Text Block Significant Accounting Policies Disclosure of accounting policy of Australian Tax Incentive Australian Tax Incentive Policy Text Block Tax Incentive Receivable Disclosure of accounting policy for recognizing and measuring the impairment of finite-lived intangible assets. An entity also may disclose its accounting policy for finite-lived intangible assets to be sold. This policy excludes goodwill. Impairment or Disposal of Finite Lived Intangible Assets, Policy [Policy Text Block] Impairment of Definite Lived Intangible Assets Intangible Assets, Finite-Lived, Policy [Policy Text Block] Intangible Assets Fair Value of Financial Instruments, Policy [Policy Text Block] Fair Value of Financial Instruments Research and Development Expense, Policy [Policy Text Block] Research and Development Expenses Earnings Per Share, Policy [Policy Text Block] Net (loss) income per share New Accounting Pronouncements, Policy [Policy Text Block] Recently Issued but not yet Adopted Accounting Pronouncements Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule of financial assets and liabilities measured at fair value on a recurring basis Schedule of Black-Scholes option pricing model assumptions Schedule of Black-Scholes option pricing model assumptions Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Schedule of warrant liability activity Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of the components of basic and diluted net (loss) income per share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of antidilutive securities which have been excluded from the computation of diluted weighted average shares outstanding Schedule of Prepaid Expenses and Other Current Assets [Table Text Block] Schedule of prepaid expenses and other current assets Schedule of Accrued Expenses and Other Current Liabilities [Table Text Block] Schedule of accrued expenses and other current liabilities Schedule of Finite-Lived Intangible Assets [Table Text Block] Schedule of intangible assets Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Schedule of future amortization of intangible assets Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Schedule of warrants outstanding and warrant activity Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Stock-based compensation Summary of Significant Accounting Policies Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Schedule of stock-based compensation expense Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Schedule of stock option activity Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of weighted-average assumptions used for estimating the fair value of the stock compensation granted Schedule of Unvested Restricted Stock Units Roll Forward [Table Text Block] Summary of RSU activity Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of segment reporting information, by segment Nature of Business Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary, Sale of Stock [Line Items] Nature of Business Number of programs grouped as asset. Number of Programs Grouped as Asset Number of programs Represents the number of clinical programs. Number of clinical programs (in programs) Number of clinical programs (in programs) Number of Operating Segments Number of operating segments Schedule of Cash and Cash Equivalents [Table] Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Domain] Represents information pertaining to Morgan Stanley institutional liquidity fund. Morgan Stanley Institutional Liquidity Fund Cash and Cash Equivalents [Line Items] Risks and Uncertainties [Abstract] Concentrations of Credit Risk and Off-Balance Sheet Risk Fair Value Disclosure, Off-balance Sheet Risks, Amount, Asset Off-balance sheet risk, asset Fair Value Disclosure, Off-balance Sheet Risks, Amount, Liability Off-balance sheet risk, liability Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Subsequent Event [Table] Subsequent Event. Amount representing reduction in research and development expense. Tax Incentive Receivable, Reduction In Research And Development Expense Research and development expense Impairment of Intangible Assets, Finite-Lived Impairment losses Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life Purchased assets, useful life Fair Value Measurements, Recurring and Nonrecurring [Table] Measurement Frequency [Axis] Fair Value, Measurement Frequency [Domain] Recurring basis Recurring basis Fair Value, Hierarchy [Axis] Fair Value Hierarchy [Domain] Level 1 Level 3 Asset Class [Axis] Asset Class [Domain] Money Market Funds [Member] Money market funds Liability Class [Axis] Fair Value by Liability Class [Domain] Information pertaining to Series A warrants. Series A Warrants [Member] Series A Warrants Sale of Stock [Axis] Sale of Stock [Domain] Represents information pertaining to the Securities Purchase Agreement. Security Purchase Agreement [Member] Securities Purchase Agreement Class of Stock [Axis] Class of Stock [Domain] Information pertaining to Class A Units. Class A Units [Member] Class A units Information pertaining to Class B Units. Class B Units [Member] Class B units Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Pre-funded warrants. Pre-funded warrants Pre-funded Warrants Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Summary of Significant Accounting Policies Assets, Fair Value Disclosure [Abstract] Assets: Cash and Cash Equivalents, Fair Value Disclosure Cash equivalents Liabilities, Fair Value Disclosure [Abstract] Liabilities: Number of units issued during the period. Units Issued During Period, New Issues Units issued Represents the number of shares in a unit. Number Of Shares In One Unit Number of shares in one unit Represents the number of warrants in a unit. Number Of Warrants In One Unit Number of warrants in one unit Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Shares into which each warrant can be converted (in shares) Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Measurement Input Type [Axis] Measurement Input Type [Domain] Expected term Expected term of warrants (years) Risk-free interest rate Risk-free interest rate Expected volatility Expected volatility Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Summary of Significant Accounting Policies Warrants and Rights Outstanding, Term Expected term of warrants (years) Warrants and Rights Outstanding, Measurement Input Measurement input Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Ending balance Beginning balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Change in fair value Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Reclassification of warrant liability upon exercise of prefunded warrants and amended warrant agreements Restricted Stock Units (RSUs) Unvested restricted stock units Stock Options Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Share based payment arrangement Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Warrants. Warrants Series C Preferred Stock [Member] Series C Preferred (assumed conversion to common stock) Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Potentially dilutive securities outstanding excluded from the computation of diluted weighted average shares as they would be antidilutive Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price (in dollars per share) Warrant Exercise Price (in dollars per share) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Potentially dilutive securities outstanding excluded from the computation of diluted weighted average shares (in shares) Prepaid Expense and Other Assets, Current [Abstract] Prepaid expenses and other current assets: Amount of asset related to consideration paid in advance for research and development that provides economic benefits within a future period of one year or the normal operating cycle, if longer. Prepaid Research and Development, Current Research and development Prepaid Insurance Insurance Other Assets, Current Other Carrying value as of the balance sheet date of obligations incurred through that date and payable for research and development. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accrued Research and Development, Current Research and development Employee-related Liabilities, Current Employee compensation Accrued Professional Fees, Current Professional fees Other Accrued Liabilities, Current Other Finite-Lived Intangible Assets, Gross Patent, Gross Finite-Lived Intangible Assets, Accumulated Amortization Patent, Accumulated Amortization Amortization of Intangible Assets Amortization expense for the patent Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year 2026 (remaining 6 months) Finite-Lived Intangible Asset, Expected Amortization, Year One 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Two 2028 Finite-Lived Intangible Asset, Expected Amortization, Year Three 2029 Finite-Lived Intangible Asset, Expected Amortization, Year Four 2030 Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Finite-Lived Intangible Asset, Expected Amortization, after Year Four Thereafter Temporary Equity, by Class of Stock [Table] Temporary Equity [Line Items] Convertible Preferred Stock and Stockholders' Equity (Deficit) Conversion of Stock, Shares Converted Shares converted Represents beneficial ownership percentage, maximum shares that can be held by shareholders together with affiliates after giving effect to conversion. Beneficial Ownership Limitation Percentage Beneficial ownership percentage Represents information pertaining to At the Market Offering. At The Market offering [Member] At the Market Offering Agreement Represents information pertaining to April 2026 financing. April 2026 Financing [Member] April 2026 Financing Represents the information pertaining to April 2026 prefunded warrants. April 2026 PreFunded Warrants [Member] April 2026 pre-funded warrants Represents the information pertaining to April 2026 Series A warrants. April 2026 Series A Warrants [Member] April 2026 Series A Warrants Represents the information pertaining to April 2026 Series B warrants. April 2026 Series B Warrants [Member] April 2026 Series B Warrants Represents the information pertaining to April 2026 Series C warrants. April 2026 Series C Warrants [Member] April 2026 Series C Warrants Represents information pertaining to common stock warrants. Common Stock Warrants Common Stock Warrants Information pertaining to Series A warrants. Seriesa Warrants [Member] series A Warrant Range [Axis] Range [Domain] Minimum Minimum Aggregate purchase price of securities agreed to be issued in the financing. Sale of Stock, Aggregate Purchase Price Aggregate purchase price Number of warrants or rights issued during the period. Class of Warrant or Right, Number of Warrants or Rights Issued Warrants issued (in shares) Shares Issued, Price Per Share Issue price (in dollars per share) Purchase price per share or per unit of warrants outstanding. Class of Warrant , Purchase Price of Warrants Warrant purchase price (in dollars per share) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Stock called by warrants or rights Amount of potential gross proceeds from warrants or rights, if the warrants or rights are fully exercised. Class Of Warrant Or Right, Potential Gross Proceeds From Warrants Or Rights Exercised Potential additional gross proceeds Threshold percentage of exercise price for the warrants or rights to be exercised forcefully. Class Of Warrant Or Right, Forced Exercise, Threshold Percentage Of Exercise Price Threshold percentage of exercise price Number of consecutive trading days during which the exercise price equals or exceeds the threshold percentage for the warrants or rights to be exercised forcefully. Class Of Warrant Or Right, Forced Exercise, Number Of Consecutive Trading Days Number of consecutive trading days The redemption price of warrant or right at which it is redeemed after the redemption period. Class Of Warrant Or Right Redemption Price Redemption price (in dollars per share) Maximum beneficial ownership percentage that a warrant or right holder may own after exercise of warrants. Class Of Warrant Or Right Maximum Beneficial Interest Percentage Beneficial ownership limitation percentage Maximum beneficial ownership percentage that a warrant or right holder may own after exercise of warrants if holder elects higher ownership cap. Class Of Warrant Or Right Maximum Beneficial Interest Percentage, At Holder Option Maximum beneficial ownership percentage Number of outstanding warrants or rights are exercisable. Class Of Warrants Or Rights, Exercisable Warrants exercisable Represents cash success fee as a percentage of upfront gross proceeds. Cash Success Fee, Percentage Of Upfront Gross Proceeds Percentage of cash success fee Sale of Stock, Consideration Received on Transaction Net proceeds Represents the threshold percentage of outstanding common stock for the change of control. Percentage of Outstanding Common Stock For Change of Control Percentage of outstanding common stock for change of control Number of specified total trading days for adjustments of exercise price for calculating volume weighted average price. Class Of Warrant Or Right, Adjustments Of Exercise Price, Total Trading Days For Calculating Volume Weighted Average Price Total trading days for calculating volume weighted average price Number of specified trading days after preceding event for adjustments of exercise price for calculating volume weighted average price. Class Of Warrant Or Right, Adjustments Of Exercise Price, Trading Days Preceding Event: For Calculating Volume Weighted Average Price Trading days preceding the event for calculating volume weighted average price Number of specified trading days following event for adjustments of exercise price for calculating volume weighted average price. Class Of Warrant Or Right, Adjustments Of Exercise Price, Trading Days Following Event: For Calculating Volume Weighted Average Price Trading days following the event for calculating volume weighted average price Represents the number of common stock issued for exercise of prefunded warrants. Stock Issued During Period, Shares, Exercise of Prefunded Warrants Exercise of prefunded warrants (in shares) Class of Warrant or Right [Table] Represents exercise price range one. Warrant exercise price range one [member] Warrant exercise price range one Represents exercise price range two. Warrant exercise price range two [member] Warrant exercise price range two Represents exercise price range three. Warrant exercise price range three [member] Warrant exercise price range three Represents exercise price range four. Warrant exercise price range four [member] Warrant exercise price range four Represents exercise price range five. Warrant exercise price range five [member] Warrant exercise price range five Class of Warrant or Right [Line Items] Warrants Class of Warrant or Right [Roll Forward] Class of Warrant or Right [Roll Forward] Warrants outstanding and warrant activity Class of Warrant or Right, Outstanding Warrants outstanding (in shares) Plan Name [Axis] Plan Name [Domain] Represents the information pertaining to 2018 Omnibus Incentive Compensation Plan. 2018 Plan 2018 Plan Represents information pertaining to the 2021 plan. 2021 Incentive Plan 2021 Incentive Plan Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent event Subsequent Events Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract] Stock-Based Compensation Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized Additional shares authorized (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Shares available for future issuance (in shares) Employee Service Share-based Compensation, Tax Benefit from Compensation Expense Net tax benefits related to the stock-based compensation costs Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Income Statement Location [Axis] Income Statement Location [Domain] Research and development Research and development General and administrative General and administrative Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] Employee Service Share-based Compensation, Aggregate Disclosures [Abstract] Stock-Based Compensation Allocated Share-based Compensation Expense Total stock-based compensation expense Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Number of Shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Balance at the end of the period (in shares) Balance at the beginning of the period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Forfeitures and expirations (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Exercisable at the end of the period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Vested and expected to vest (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Weighted-Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Balance at the end of the period (in dollars per share) Balance at the beginning of the period (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Forfeitures and expirations (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Exercisable at the end of the period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Vested and expected to vest (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Additional Disclosures Stock-Based Compensation Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Term Of Options Outstanding (in years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Term Of Options Exercisable (in years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Weighted average remaining contractual term of options vested or expected to vest Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Aggregate Intrinsic Value - Balance at the end of the period Aggregate Intrinsic Value - Balance at the beginning of the period Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Aggregate intrinsic value of options vested or expected to vest Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Aggregate intrinsic value of options exercisable Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options Unrecognized compensation expense related to unvested stock options Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Weighted-average period for recognizing unrecognized compensation expense (in years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] Assumptions used Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk-free interest rate (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected volatility (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Expected term (in years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Expected dividend yield (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted average grant date fair value (in dollars per share) Grantee Status [Axis] Grantee Status [Domain] Employee Employee Vesting [Axis] Vesting [Domain] Vesting Percentage One Vesting on each of the first and second anniversary Vesting Percentage Two Vesting on third anniversary Inducement RSUs [Member] Inducement RSUs [Member] Inducement RSUs Represents information pertaining to service based restricted stock units Service Based Restricted Stock Units [Member] Service based RSU Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Vesting (Percentage) Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Unrecognized compensation cost related to awards other than options Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number Outstanding and unvested, ending balance, Number of Units (in shares) Outstanding and unvested, beginning balance, Number of Units (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised Vested, Number of Units (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Outstanding and unvested, ending balance, Weighted average grant date fair value (in dollars per share) Outstanding and unvested, beginning balance, Weighted average grant date fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Vested, Weighted average grant date fair value (in dollars per share) Schedule of Segment Reporting Information, by Segment [Table] Segments [Axis] Segments [Domain] Represents information pertaining to the single reportable segment of the company. Single Reportable Segment [Member] Single reportable segment Segment Reporting Information [Line Items] Segment Information Number of Reportable Segments Number of reportable segments Research and Development Expense [Abstract] Research and development expenses: Research and development expense during the period related to the preclinical and clinical development cost. Research and Development Expense, Preclinical And Clinical Development Preclinical & clinical development The amount of personnel expense incurred during the period included in research and development expense. Research and Development Expense, Personnel Expense Personnel related Other Research and Development Expense Other research and development General and Administrative Expense [Abstract] General and administrative expenses: Professional Fees Professional & consulting fees Labor and Related Expense Personnel related Other General and Administrative Expense Other general and administrative Schedule of Related Party Transactions, by Related Party [Table] Related Party [Axis] Related Party [Domain] Related Party [Member] Related Party Counterparty Name [Axis] Counterparty Name [Domain] Represents information pertaining to ChemDiv, Inc. ChemDiv, Inc [Member] ChemDiv Balance Sheet Location [Axis] Balance Sheet Location [Domain] Accounts Payable [Member] Accounts Payable Related Party Transaction [Line Items] Research and Development Arrangements and Related Party Transactions Carrying value as of the balance sheet date of obligations incurred and payable for research and development. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Research And Development, Amount Payable Research and development payable n/a Rule 10b5-1 Arr Modified [Flag] Rule 10b5-1 Arrangement Modified n/a Non Rule 10b5-1 Arr Modified [Flag] Non-Rule 10b5-1 Arrangement Modified